MyAverix Finance
F · Healthcare
VIVORYON THERAPEUTICS (05Y)
Biotechnology
VIVORYON THERAPEUTICS (05Y) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $36.57M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 05Y
VIVORYON THERAPEUTICS (05Y) — FAQ
What is VIVORYON THERAPEUTICS's market cap?
VIVORYON THERAPEUTICS (05Y) has a reported market cap of $36.57M (data as of 2026-05-24).
What is 05Y's P/E ratio?
The price-to-earnings (P/E) ratio for VIVORYON THERAPEUTICS (05Y) is 25.00 (data as of 2026-05-24).
Does VIVORYON THERAPEUTICS pay a dividend?
Dividend yield is not available in the current snapshot for VIVORYON THERAPEUTICS (05Y). Check the MyAverix Finance app for the latest dividend data.
What sector is VIVORYON THERAPEUTICS in?
VIVORYON THERAPEUTICS (05Y) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 05Y listed on?
05Y is listed on F.
What is VIVORYON THERAPEUTICS's net margin?
VIVORYON THERAPEUTICS (05Y) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.